Home › SEC Filings
SEC Filing Analysis
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| TGTX | INST-CLUSTER | mixed | 4/10 | In Q3 2024, institutional activity in TGTX reveals a sharp split: 16 buyers added $41.8M in positions, led by asset mana | Jun 11, 2026 |
| ANRO | INST-CLUSTER | bullish | 7/10 | Ten institutional investors accumulated $17.7M in ANRO during Q3 2024, with zero sellers, signaling strong conviction in | Jun 11, 2026 |
| SLNO | INST-CLUSTER | bullish | 6/10 | 15 institutional investors accumulated positions in SLNO during Q3 2024, with Pictet Asset Management ($29.1M) and Inves | Jun 11, 2026 |
| CMPX | INST-CLUSTER | mixed | 4/10 | A mixed institutional cluster in CMPX for Q3 2024 shows 6 buyers accumulating $11.0M net (led by Blackstone adding $10.8 | Jun 11, 2026 |
| QNCX | 3 | neutral | 2/10 | Brigette Roberts filed a Form 3 initial beneficial ownership statement upon becoming Chief Corp. Affairs Officer at Quin | Jun 11, 2026 |
| ADMA | INST-CLUSTER | mixed | 5/10 | A mixed institutional cluster in ADMA BIOLOGICS for Q3 2024 shows 21 buyers accumulating $86.6M in net new positions (to | Jun 11, 2026 |
| CABA | INST-CLUSTER | neutral | 5/10 | { "summary": "An institutional cluster for Cabaletta Bio (CABA) from Q3 2024 reveals heavy distribution: Alkeon Capita | Jun 11, 2026 |
| AVBP | INST-CLUSTER | bullish | 4/10 | Six institutional investors accumulated AVBP shares in Q3 2024 with zero sellers, adding a net $4.4M to aggregate holdin | Jun 11, 2026 |
| RGEN | INST-CLUSTER | neutral | 5/10 | { "summary": "During Q3 2024, an institutional cluster in REPLIGEN CORP (RGEN) showed a mixed but net-buying pattern: | Jun 11, 2026 |
| PALI | 8-K | neutral | 4/10 | Palisade Bio filed an 8-K reporting its 2026 annual meeting results, including stockholder approval to increase authoriz | Jun 11, 2026 |
| OCGN | 8-K | neutral | 2/10 | Ocugen filed an 8-K reporting results from its June 11, 2026 Annual Meeting and the formal appointment of Mohamed Genead | Jun 11, 2026 |
| AXSM | 144 | neutral | 1/10 | Director Roger Jeffs filed a Form 144 to sell 286 shares of Axsome Therapeutics common stock, valued at approximately $7 | Jun 11, 2026 |
| QDEL | INST-CLUSTER | mixed | 5/10 | QDEL saw a mixed institutional cluster in Q3 2024: 9 buyers added $136.9M in new holdings (led by Invesco doubling to $9 | Jun 11, 2026 |
| ZNTL | INST-CLUSTER | mixed | 4/10 | Institutional cluster for ZNTL in Q3 2024 reveals a mixed picture: D.E. Shaw doubled its position to $4.2M and Balyasny | Jun 11, 2026 |
| SVRA | INST-CLUSTER | mixed | 4/10 | Institutional cluster for SVRA (Savara Inc) shows mixed signals: 5 buyers added $3.7M in new holdings, but one major hol | Jun 11, 2026 |
| HROW | INST-CLUSTER | mixed | 5/10 | Four institutions added $46.3M to HROW positions in Q3 2024, led by D.E. Shaw's new $28M stake, while two asset managers | Jun 11, 2026 |
| SHPH | 8-K | neutral | 3/10 | Shuttle Pharmaceuticals filed a Certificate of Amendment to effect a 1-for-10 reverse stock split of its common stock, e | Jun 11, 2026 |
| HUMA | 8-K | bearish | 6/10 | Humacyte priced a $50M underwritten public offering of 47.6M shares at $1.05/share, with an underwriter option for an ad | Jun 11, 2026 |
| ANIK | INST-CLUSTER | bearish | 4/10 | An institutional cluster for ANIK shows 4 small asset managers adding a combined $33K, while Citadel trimmed 52.8% of it | Jun 11, 2026 |
| QURE | 144 | neutral | 2/10 | Director Balachandran Madhavan filed a Form 144 indicating intent to sell 11,993 ordinary shares of uniQure N.V. via Cit | Jun 11, 2026 |
| ACIU | 6-K | neutral | 2/10 | AC Immune held its Annual General Meeting on June 11, 2026, where shareholders approved all routine agenda items includi | Jun 11, 2026 |
| IQV | 8-K | neutral | 3/10 | IQVIA Inc., a wholly-owned subsidiary of IQVIA Holdings Inc., completed the issuance and sale of €950,000,000 in aggrega | Jun 11, 2026 |
| ANAB | 144 | bearish | 6/10 | Dennis Mulroy, an officer of AnaptysBio, filed a Form 144 notice of intent to sell 35,000 common shares valued at approx | Jun 11, 2026 |
| KYTX | INST-CLUSTER | bearish | 5/10 | A mixed institutional cluster in Kyverna Therapeutics (KYTX) for Q3 2024 shows two small buyers (Schwab and Federated He | Jun 11, 2026 |
| KALV | 8-K | neutral | 5/10 | Chiesi Farmaceutici S.p.A. completed its acquisition of KalVista Pharmaceuticals for $27.00 per share in cash through a | Jun 11, 2026 |
| NUVL | CLUSTER | neutral | 2/10 | Two Nuvalent insiders (CEO and Chief Development Officer) sold a combined ~$3.56M in open-market shares on June 8-9, 202 | Jun 11, 2026 |
| AIM | 8-K | bearish | 7/10 | AIM ImmunoTech entered a Securities Purchase Agreement for up to ~$2.65M in shares and Class J warrants at $0.5189/share | Jun 11, 2026 |
| RVMD | 144 | neutral | 3/10 | Director Margaret A. Horn files Form 144 notice of intent to sell 10,000 shares (~$1.44M based on stated value). This is | Jun 11, 2026 |
| ONC | 144 | neutral | 2/10 | Director John Oyler filed a Form 144 notice of intent to sell 1,949 ADSs (~$501K) of BeOne Medicines Ltd. (ONC), with pr | Jun 11, 2026 |
| QURE | 144 | neutral | 2/10 | Director Leonard E. Post filed a Form 144 notice of intent to sell 1,993 ordinary shares of uniQure N.V., with an approx | Jun 11, 2026 |